Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Philip F. Morgan
Introduction
Philip F. Morgan is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical technology, particularly in drug delivery systems. His innovative approach has the potential to enhance treatment options for patients with heart conditions.
Latest Patents
Morgan holds a patent for a "Myocardial drug delivery apparatus and method." This invention provides apparatus and methods for delivering solid form drugs (SFD) to various locations in the body. One embodiment of the invention includes an apparatus designed for the treatment of arrhythmia, which comprises a drug delivery member (DDM) coupled to a drug storage device (DSD). The DSD is configured to store and advance SFD, such as drug pellets, through the DDM to a target tissue site (TTS) in or on the heart. A drug advancement member may be utilized to facilitate the movement of the SFD through the DSD. Additionally, a capture chamber (CC) can be coupled to the DDM, allowing SFD to dissolve and deliver a drug solution to the heart. The DSD can be implanted subcutaneously, for example, in the pectoral area. This apparatus can store and deliver SFD to the heart or other TTS over an extended period of years.
Career Highlights
Morgan is associated with Incube Labs, LLC, where he continues to develop innovative medical technologies. His work focuses on improving drug delivery methods, which can significantly impact patient care and treatment outcomes.
Collaborations
Morgan has collaborated with notable professionals in the field, including Mir A. Imran and Paul Spehr. These collaborations have contributed to the advancement of his inventions and the development of new technologies.
Conclusion
Philip F. Morgan's contributions to medical technology, particularly in drug delivery systems, demonstrate his commitment to innovation and improving patient care. His patent for the myocardial drug delivery apparatus showcases his ability to address critical medical challenges.